| http://www.w3.org/ns/prov#value | - The results, published online in the Journal of the American Medical Association, found the medicines didn???t delay progress of the patients??? disability.???It dampens somewhat the enthusiasm for so-called first- line therapies,??? said Ludwig Kappos of University Hospital in Basel, Switzerland, and author of an editorial that accompanied the study, in an e-mail.MS is an autoimmune disease that
|
